Organoids, air-liquid-interface cultures, and microfluidic culture systems are only a few examples of new alternative methods (or new approach methods; NAMs) that have become an increasingly important tool for biopharmaceutical research. Both as a tool for studying disease mechanisms and as a platform for testing novel therapeutics NAMs represent a paradigm shift in translational in-vitro models and offer improved reproducibility and human translatability relative to animal models and simpler cell-based systems. The increasing adoption of NAMs also aligns with FDA Modernization Act 3.0 and increased implementation of the 3Rs principle (Replacement, Reduction, and Refinement) in animal research.
Microscopy and Microanalysis.
2025;31(Supplement_1):ozaf048.449. doi: 10.1093/mam/ozaf048.449
Library Collection(s)